[go: up one dir, main page]

RU2002119319A - Antibacterial pharmaceutical composition - Google Patents

Antibacterial pharmaceutical composition

Info

Publication number
RU2002119319A
RU2002119319A RU2002119319/15A RU2002119319A RU2002119319A RU 2002119319 A RU2002119319 A RU 2002119319A RU 2002119319/15 A RU2002119319/15 A RU 2002119319/15A RU 2002119319 A RU2002119319 A RU 2002119319A RU 2002119319 A RU2002119319 A RU 2002119319A
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
antibacterial pharmaceutical
macrolide
antibiotic
stearic acid
Prior art date
Application number
RU2002119319/15A
Other languages
Russian (ru)
Other versions
RU2223103C1 (en
Inventor
Светлана Александровна Еремкина
Светлана Сергеевна Фомичева
Original Assignee
Открытое акционерное общество "Биосинтез"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Открытое акционерное общество "Биосинтез" filed Critical Открытое акционерное общество "Биосинтез"
Priority to RU2002119319/15A priority Critical patent/RU2223103C1/en
Application granted granted Critical
Publication of RU2223103C1 publication Critical patent/RU2223103C1/en
Publication of RU2002119319A publication Critical patent/RU2002119319A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Claims (1)

Фармацевтическая композиция, обладающая антибактериальным действием, содержащая действующее вещество - антибиотик-макролид и целевые добавки, отличающаяся тем, что в качестве антибиотика-макролида содержит азитромицина дигидрад, в качестве целевых добавок - кальций стеариновокислый, крахмал кукурузный, целлюлозу микрокристаллическую, при следующем соотношении компонентов, г на 1 капсулу:A pharmaceutical composition having an antibacterial effect, containing the active substance - antibiotic-macrolide and target additives, characterized in that it contains azithromycin dihydrad as antibiotic-macrolide, calcium stearic acid, corn starch, microcrystalline cellulose in the following ratio of components, g per 1 capsule: Азитромицина дигидрат 0,2682Azithromycin dihydrate 0.2682 Кальций стеариновокислый 0,0080Calcium stearic acid 0,0080 Крахмал кукурузный 0,04Corn starch 0.04 Целлюлоза микрокристаллическая 0,0338Microcrystalline cellulose 0.0338
RU2002119319/15A 2002-07-17 2002-07-17 Pharmaceutical composition eliciting antibacterial effect RU2223103C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2002119319/15A RU2223103C1 (en) 2002-07-17 2002-07-17 Pharmaceutical composition eliciting antibacterial effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2002119319/15A RU2223103C1 (en) 2002-07-17 2002-07-17 Pharmaceutical composition eliciting antibacterial effect

Publications (2)

Publication Number Publication Date
RU2223103C1 RU2223103C1 (en) 2004-02-10
RU2002119319A true RU2002119319A (en) 2004-02-20

Family

ID=32173029

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002119319/15A RU2223103C1 (en) 2002-07-17 2002-07-17 Pharmaceutical composition eliciting antibacterial effect

Country Status (1)

Country Link
RU (1) RU2223103C1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3897658A4 (en) * 2018-12-17 2022-10-19 Lunella Biotech, Inc. TRIPLE COMBINATION THERAPIES TO TARGET MITOCHONDRIA AND KILL CANCER STEM CELLS

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR20190524A (en) 2017-05-19 2020-01-10 Lunella Biotech Inc Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
US11497759B2 (en) 2017-12-01 2022-11-15 Lunella Biotech, Inc. Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
MX2021007347A (en) * 2018-12-17 2021-07-15 Lunella Biotech Inc TRIPLE COMBINATION THERAPIES FOR ANTI-AGING.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
TW271400B (en) * 1992-07-30 1996-03-01 Pfizer
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
RU2188018C2 (en) * 2000-06-20 2002-08-27 Нестерук Владимир Викторович Composition of antibacterial medicinal preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3897658A4 (en) * 2018-12-17 2022-10-19 Lunella Biotech, Inc. TRIPLE COMBINATION THERAPIES TO TARGET MITOCHONDRIA AND KILL CANCER STEM CELLS

Also Published As

Publication number Publication date
RU2223103C1 (en) 2004-02-10

Similar Documents

Publication Publication Date Title
NO2025027I1 (en) Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - extended.
RU2015151938A (en) TABLETABLE MEDICINE (4'-TRIFFORMETHYLPHENYL) AMID (Z) -2-CYANO-3-HYDROXY-BUT-2-ENOIC ACID WITH IMPROVED STABILITY
RU96116411A (en) QUICKLY DISPERSABLE READY-FORMED DRUG FORM TRAMADOL OR TRAMADOL SALT
PT1007006E (en) FORMULATION OF CEFADROXIL MONO-HYDRATE TABLET
WO2007134158A3 (en) Granules comprising calcium carbonate, a binder and a porosity increasing agent, processes of manufacturing, use in therapy
CA2489140A1 (en) Dosage form containing pantoprazole as active ingredient
EP2103306A3 (en) Use of a 5'-nucleotide for preventing/improving functional digestive disorder
RU2002119319A (en) Antibacterial pharmaceutical composition
WO2008037359A3 (en) Active ingredient containing stabilised solid medicinal forms and method for the production thereof
IL174655A0 (en) Drug containing (2r)-2-propyloctanoic acid as the active ingredient
RU2000115604A (en) COMPOSITION OF ANTIBACTERIAL MEDICINE
PT1202956E (en) THERAPEUTIC AND / OR NURITIONALLY IMPROVED DERIVATIVES OF ACTIVE INGREDIENTS AND ORAL ADMINISTRATION COMPOSITIONS CONTAINING THE SAME
EP2801359A3 (en) The use of nicotine for the treatment of sepsis in humans caused by antibiotic
CA2551975A1 (en) System for the liberation of an active principle and its use
RU2002125813A (en) ANTIBACTERIAL MEANS
RU2003104272A (en) ANTIFUNGAL PHARMACEUTICAL COMPOSITION
RU2006109966A (en) YANTASTIM-S DRUG FOR THERAPY AND PREVENTION OF ANIMAL INFECTIOUS DISEASES
RU2001105595A (en) Veterinary drug
RU2004109902A (en) HEALING FOOD FOR FISH
RU2001131215A (en) Pharmaceutical composition for the treatment of fungal diseases
NO20041878L (en) Carboxylic acid derivative compounds and drugs containing the same as the active ingredient.
RU2002110957A (en) Hepatoprotective agent "Karsilin"
RU2003131617A (en) INSECTICIDAL COMPOSITION FOR THE STRUGGLE AGAINST THE EAG-2 GARBARS
RU2003115414A (en) BIOLOGICALLY ACTIVE PREPARATION "ENTEROMIXIN"
RU99115848A (en) LIMED FERTILIZER

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20190718